المؤلفون: Jensen, Mia, Eickhoff, Mie K., Persson, Frederik, Rossing, Peter, Thiel, Steffen, Hansen, Søren, Palarasah, Yaseelan, Svenningsen, Per, Jensen, Boye Lagerbon

المصدر: Jensen , M , Eickhoff , M K , Persson , F , Rossing , P , Thiel , S , Hansen , S , Palarasah , Y , Svenningsen , P & Jensen , B L 2024 , ' Effect of dapagliflozin on collectins and complement activation in plasma from patients with type 2 diabetes and albuminuria: Data from the DapKid cohort ' , Immunobiology , vol. 229 , no. 3 , 152797 . https://doi.org/10.1016/j.imbio.2024.152797Test

مصطلحات موضوعية: Albuminuria, Complement system, Lectin cascade, SGLT-2 inhibitor, Type 2 diabetes mellitus

وصف الملف: application/pdf

العلاقة: https://portal.findresearcher.sdu.dk/da/publications/e320dc72-4053-46c7-9483-6f758be30be6Test

الإتاحة: https://doi.org/10.1016/j.imbio.2024.152797Test
https://portal.findresearcher.sdu.dk/da/publications/e320dc72-4053-46c7-9483-6f758be30be6Test
https://findresearcher.sdu.dk/ws/files/258282323/1-s2.0-S0171298524000159-main.pdfTest

المؤلفون: Jensen, Mia, Eickhoff, Mie K., Persson, Frederik, Rossing, Peter, Thiel, Steffen, Hansen, Søren W.K., Palarasah, Yaseelan, Svenningsen, Per, Jensen, Boye L.

المصدر: Jensen , M , Eickhoff , M K , Persson , F , Rossing , P , Thiel , S , Hansen , S W K , Palarasah , Y , Svenningsen , P & Jensen , B L 2024 , ' Effect of dapagliflozin on collectins and complement activation in plasma from patients with type 2 diabetes and albuminuria : Data from the DapKid cohort ' , Immunobiology , vol. 229 , no. 3 , 152797 . https://doi.org/10.1016/j.imbio.2024.152797Test

مصطلحات موضوعية: Albuminuria, Complement system, Lectin cascade, SGLT-2 inhibitor, Type 2 diabetes mellitus

وصف الملف: application/pdf

الإتاحة: https://doi.org/10.1016/j.imbio.2024.152797Test
https://curis.ku.dk/portal/da/publications/effect-of-dapagliflozin-on-collectins-and-complement-activation-in-plasma-from-patients-with-type-2-diabetes-and-albuminuriaTest(7a64e404-e257-4893-98b9-76a2e3bdb755).html
https://curis.ku.dk/ws/files/387240747/1_s2.0_S0171298524000159_main.pdfTest

المؤلفون: Yeoh, Su Ern, Docherty, Kieran F., Campbell, Ross T., Jhund, Pardeep S., Hammarstedt, Ann, Heerspink, Hiddo J.L., Jarolim, Petr, Køber, Lars, Kosiborod, Mikhail N., Martinez, Felipe A., Ponikowski, Piotr, Solomon, Scott D., Sjöstrand, Mikaela, Bengtsson, Olof, Greasley, Peter J., Sattar, Naveed, Welsh, Paul, Sabatine, Marc S., Morrow, David A., McMurray, John J.V.

المصدر: Yeoh , S E , Docherty , K F , Campbell , R T , Jhund , P S , Hammarstedt , A , Heerspink , H J L , Jarolim , P , Køber , L , Kosiborod , M N , Martinez , F A , Ponikowski , P , Solomon , S D , Sjöstrand , M , Bengtsson , O , Greasley , P J , Sattar , N , Welsh , P , Sabatine , M S , Morrow , D A & McMurray , J J V 2023 , ' Endothelin-1, Outcomes in ....

مصطلحات موضوعية: biomarkers, endothelin-1, heart failure, kidney, SGLT-2 inhibitor

وصف الملف: application/pdf

العلاقة: https://research.rug.nl/en/publications/158f159c-1c1c-4a90-a6a6-879c01457870Test

الإتاحة: https://doi.org/10.1161/CIRCULATIONAHA.122.063327Test
https://hdl.handle.net/11370/158f159c-1c1c-4a90-a6a6-879c01457870Test
https://research.rug.nl/en/publications/158f159c-1c1c-4a90-a6a6-879c01457870Test
https://pure.rug.nl/ws/files/825230061/Endothelin-1_Outcomes_in_Patients_With_Heart_Failure_and_Reduced_Ejection_Fraction_and_Effects_of_Dapagliflozin_Findings_From_DAPA-HF.pdfTest
http://www.scopus.com/inward/record.url?scp=85160841821&partnerID=8YFLogxKTest

المؤلفون: Biegus, Jan, Voors, Adriaan A., Collins, Sean P., Kosiborod, Mikhail N., Teerlink, John R., Angermann, Christiane E., Tromp, Jasper, Ferreira, Joao Pedro, Nassif, Michael E., Psotka, Mitchell A., Brueckmann, Martina, Salsali, Afshin, Blatchford, Jonathan P., Ponikowski, Piotr

المصدر: Biegus , J , Voors , A A , Collins , S P , Kosiborod , M N , Teerlink , J R , Angermann , C E , Tromp , J , Ferreira , J P , Nassif , M E , Psotka , M A , Brueckmann , M , Salsali , A , Blatchford , J P & Ponikowski , P 2023 , ' Impact of empagliflozin on decongestion in acute heart failure : the EMPULSE trial ' , European Heart Journal , vol. 44 , no. 1 , ehac530 . https://doi.org/10.1093/eurheartj/ehac530Test

مصطلحات موضوعية: SGLT-2 inhibitor, Decongestion, Acute heart failure, Empagliflozin, DIURETIC RESPONSE, WIN RATIO, CONGESTION

وصف الملف: application/pdf

العلاقة: https://research.rug.nl/en/publications/ed9170a6-6d54-4389-af0f-3f27e3803d41Test

الإتاحة: https://doi.org/10.1093/eurheartj/ehac530Test
https://hdl.handle.net/11370/ed9170a6-6d54-4389-af0f-3f27e3803d41Test
https://research.rug.nl/en/publications/ed9170a6-6d54-4389-af0f-3f27e3803d41Test
https://pure.rug.nl/ws/files/252490917/ehac530.pdfTest

المؤلفون: Bauersachs, Johann, de Boer, Rudolf A., Lindenfeld, JoAnn, Bozkurt, Biykem

المصدر: Bauersachs , J , de Boer , R A , Lindenfeld , J & Bozkurt , B 2022 , ' The year in cardiovascular medicine 2021 : heart failure and cardiomyopathies ' , European Heart Journal , vol. 43 , no. 5 , pp. 367-376 . https://doi.org/10.1093/eurheartj/ehab887Test

مصطلحات موضوعية: Heart failure, Epidemiology, Imaging, Biomarkers, Pharmacotherapy, Artificial intelligence, SGLT-2 inhibitor, Angiotensin receptor-neprilysin inhibitors, Activators of soluble guanylate cyclase, Device therapy, REDUCED EJECTION FRACTION, QUALITY-OF-LIFE, DOUBLE-BLIND, COVID-19, RISK, SACUBITRIL/VALSARTAN, DAPAGLIFLOZIN, OUTCOMES, EMPAGLIFLOZIN, INHIBITORS

وصف الملف: application/pdf

العلاقة: https://research.rug.nl/en/publications/6d9e3f2c-e080-4381-9704-c1d9b1863790Test

الإتاحة: https://doi.org/10.1093/eurheartj/ehab887Test
https://hdl.handle.net/11370/6d9e3f2c-e080-4381-9704-c1d9b1863790Test
https://research.rug.nl/en/publications/6d9e3f2c-e080-4381-9704-c1d9b1863790Test
https://pure.rug.nl/ws/files/216651966/ehab887.pdfTest

المؤلفون: Vart, Priya, Correa-Rotter, Ricardo, Hou, Fan Fan, Jongs, Niels, Chertow, Glenn M., Langkilde, Anna Maria, McMurray, John J.V., Rossing, Peter, Sjöström, C. David, Stefansson, Bergur V., Toto, Robert D., Douthat, Walter, Escudero, Elizabeth, Isidto, Rey, Khullar, Dinesh, Bajaj, Harpreet S., Wheeler, David C., Heerspink, Hiddo J.L.

المصدر: Vart , P , Correa-Rotter , R , Hou , F F , Jongs , N , Chertow , G M , Langkilde , A M , McMurray , J J V , Rossing , P , Sjöström , C D , Stefansson , B V , Toto , R D , Douthat , W , Escudero , E , Isidto , R , Khullar , D , Bajaj , H S , Wheeler , D C & Heerspink , H J L 2022 , ' Efficacy and Safety of Dapagliflozin in Patients With CKD Across Major Geographic Regions ....

مصطلحات موضوعية: dapagliflozin, efficacy, regions, safety, SGLT-2 inhibitor

وصف الملف: application/pdf

الإتاحة: https://doi.org/10.1016/j.ekir.2022.01.1060Test
https://curis.ku.dk/portal/da/publications/efficacy-and-safety-of-dapagliflozin-in-patients-with-ckd-across-major-geographic-regionsTest(3e3dfc85-d5e7-4561-a6b0-d38f0b44600d).html
https://curis.ku.dk/ws/files/309126721/1_s2.0_S2468024922010841_main.pdfTest

المؤلفون: Israelsen, Simone Bastrup, Pottegård, Anton, Sandholdt, Håkon, Madsbad, Sten, Thomsen, Reimar Wernich, Benfield, Thomas

المصدر: Israelsen , S B , Pottegård , A , Sandholdt , H , Madsbad , S , Thomsen , R W & Benfield , T 2021 , ' Comparable COVID-19 outcomes with current use of GLP-1 receptor agonists, DPP-4 inhibitors or SGLT-2 inhibitors among patients with diabetes who tested positive for SARS-CoV-2 ' , Diabetes, Obesity and Metabolism , vol. 23 , no. 6 , pp. 1397-1401 . https://doi.org/10.1111/dom.14329Test

مصطلحات موضوعية: antidiabetic drug, DPP-4 inhibitor, GLP-1 analogue, population study, SGLT-2 inhibitor

الإتاحة: https://doi.org/10.1111/dom.14329Test
https://pure.au.dk/portal/da/publications/comparable-covid19-outcomes-with-current-use-of-glp1-receptor-agonists-dpp4-inhibitors-or-sglt2-inhibitors-among-patients-with-diabetes-who-tested-positive-for-sarscov2Test(402263cd-ea22-4fd0-afec-5a09c25ed8c5).html
http://www.scopus.com/inward/record.url?scp=85101446798&partnerID=8YFLogxKTest
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8014019/pdf/DOM-23-1397.pdfTest

المؤلفون: Israelsen, Simone Bastrup, Pottegård, Anton, Sandholdt, Håkon, Madsbad, Sten, Thomsen, Reimar Wernich, Benfield, Thomas

المصدر: Israelsen , S B , Pottegård , A , Sandholdt , H , Madsbad , S , Thomsen , R W & Benfield , T 2021 , ' Comparable COVID-19 outcomes with current use of GLP-1 receptor agonists, DPP-4 inhibitors or SGLT-2 inhibitors among patients with diabetes who tested positive for SARS-CoV-2 ' , Diabetes, Obesity and Metabolism , vol. 23 , no. 6 , pp. 1397-1401 . https://doi.org/10.1111/dom.14329Test

مصطلحات موضوعية: antidiabetic drug, DPP-4 inhibitor, GLP-1 analogue, population study, SGLT-2 inhibitor

وصف الملف: application/pdf

العلاقة: https://portal.findresearcher.sdu.dk/da/publications/c78121c5-dea4-4f45-8bd0-caad0315fab6Test

الإتاحة: https://doi.org/10.1111/dom.14329Test
https://portal.findresearcher.sdu.dk/da/publications/c78121c5-dea4-4f45-8bd0-caad0315fab6Test
https://findresearcher.sdu.dk/ws/files/182690503/dom.14329.pdfTest

المؤلفون: Schnell, Oliver, Standl, Eberhard, Cos, Xavier, Heerspink, Hiddo J. L., Itzhak, Baruch, Lalic, Nebojsa, Nauck, Michael, Ceriello, Antonio

المصدر: Schnell , O , Standl , E , Cos , X , Heerspink , H J L , Itzhak , B , Lalic , N , Nauck , M & Ceriello , A 2020 , ' Report from the 5th cardiovascular outcome trial (CVOT) summit ' , Cardiovascular Diabetology , vol. 19 , no. 1 , 47 . https://doi.org/10.1186/s12933-020-01022-7Test

مصطلحات موضوعية: Cardiovascular risk, Diabetes, CVOT, CAROLINA, CREDENCE, DAPA-HF, REWIND, PIONEER-6, SGLT-2 inhibitor, GLP-1 receptor agonist, DISEASE, MORTALITY

وصف الملف: application/pdf

العلاقة: https://research.rug.nl/en/publications/1b3f747a-5246-4127-ac94-35d37d925d2cTest

الإتاحة: https://doi.org/10.1186/s12933-020-01022-7Test
https://hdl.handle.net/11370/1b3f747a-5246-4127-ac94-35d37d925d2cTest
https://research.rug.nl/en/publications/1b3f747a-5246-4127-ac94-35d37d925d2cTest
https://pure.rug.nl/ws/files/149808361/s12933_020_01022_7.pdfTest

المصدر: CVD-REAL Investigators Study Grp 2018 , ' Cardiovascular Events Associated With SGLT-2 Inhibitors Versus Other Glucose-Lowering Drugs The CVD-REAL 2 Study ' , Journal of the American College of Cardiology , vol. 71 , no. 23 , pp. 2628-2639 . https://doi.org/10.1016/j.jacc.2018.03.009Test

مصطلحات موضوعية: death, diabetes mellitus, heart failure, observational studies, sodium glucose cotransporter-2 inhibitors, SGLT-2 inhibitor, ALL-CAUSE MORTALITY, JAPANESE HOSPITAL DATABASE, SEVERE HYPOGLYCEMIA, LOWER RISK, DPP-4 INHIBITORS, ASIA, SULFONYLUREA, ORGANIZATION, INITIATION

وصف الملف: application/pdf

العلاقة: https://research.rug.nl/en/publications/4c8e59cb-6319-46b1-beb8-e3282bda4978Test

الإتاحة: https://doi.org/10.1016/j.jacc.2018.03.009Test
https://hdl.handle.net/11370/4c8e59cb-6319-46b1-beb8-e3282bda4978Test
https://research.rug.nl/en/publications/4c8e59cb-6319-46b1-beb8-e3282bda4978Test
https://pure.rug.nl/ws/files/75449085/1_s2.0_S0735109718335289_main.pdfTest